Medtronic Announces CRYSTAL AF Trial Showed Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients Better Than Standard Care

By: via Benzinga
Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.